Co-Founding Partner and COO
Chief Financial Officer
Chief People Officer
Partner, Launch Excellence Practice Lead
Partner, Patient Services Practice Lead
Partner, Market Access Practice Lead
General Manager, SixSense Strategy Group, Medical Affairs Practice Lead
Principal, Market Access
Principal, Medical Communications
Principal, Value and Access Communications
Principal, Evidence and Value
Managing Director, Adivo
Principal, Science and Strategy
Managing Director, Adivo
Director, Adivo
Principal, Evidence and Value
Managing Director, Adivo
Principal, Market Access
Principal, Market Access
Principal
Principal
Principal, Science and Strategy
Senior Vice President, Commercialization
Vice President, Commercialization
Senior Vice President, Commercialization
Vice President, Business Development
Executive Vice President, Business Development
Senior Vice President, Commercialization
Zo is a co-founder of sixsense strategy group. He is a thought provoking business leader with a gift for strategy. He likes to keep strategy simple and focused on meeting the needs of key stakeholders – patients, HCPs, payers and regulators.
Zo has worked extensively in the Life Science Industry in Canada, the US and Europe. He has supported both leadership teams and cross-functional teams in development of strategy. He is excited and inspired by the focus that Sixsense has placed on supporting young life sciences companies to prepare for their first launch of novel and innovative first therapies.
Spending time with his family, experiencing new adventures and creating memories are most important to Zo. He loves cars, building things with his hands, fishing and just about any sport (except curling).
Our biotech client was facing the challenge of introducing a new competitor into the market while simultaneously gaining a deeper understanding of their disease state. To navigate this complex scenario, they needed a strategic document that would serve as the foundation for both internal and external communications.
Our client, a leading biopharmaceutical company, sought to embark on a clinical development program within a new therapeutic area in the rare disease space. Read the case study.
A recent pivotal Phase 3 clinical trial marked a significant milestone for our client, a biopharmaceutical company, in their quest to introduce a novel treatment for major depressive disorder (MDD). Read more.
Careers page, Principal profile
"*" indicates required fields
Careers page Analyst profile
Careers page Manager profile